The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians
- PMID: 15191688
- DOI: 10.1007/s11894-004-0037-y
The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians
Abstract
The phenotypic classification of pancreatic neoplasms is based on their cellular lineage. Thus, tumors with a ductal, acinar, and endocrine phenotype can be distinguished. Most pancreatic neoplasms show a ductal phenotype and can be classified as ductal adenocarcinomas. Less common tumors with a ductal phenotype are the variants of ductal adenocarcinoma, intraductal papillary mucinous neoplasm (including colloid carcinoma), mucinous cystic neoplasm, medullary carcinoma, and other rare tumors. Ductal adenocarcinomas most likely develop from ductal proliferative lesions arising in the pancreatic duct system. A recently adopted classification system for these lesions distinguishes between three grades of pancreatic intraepithelial neoplasia (PanIN). Molecular studies have revealed that PanIN-2 and PanIN-3 lesions represent a distinct step toward invasive carcinoma.
Similar articles
-
Where and when does pancreatic carcinoma start?Med Klin (Munich). 2004 Apr 15;99(4):191-5. doi: 10.1007/s00063-004-1028-3. Med Klin (Munich). 2004. PMID: 15085289
-
Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.Dig Dis. 2001;19(1):15-23. doi: 10.1159/000050649. Dig Dis. 2001. PMID: 11385247 Review.
-
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6. J Hepatobiliary Pancreat Sci. 2013. PMID: 23475261
-
Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.Semin Radiat Oncol. 2005 Oct;15(4):254-64. doi: 10.1016/j.semradonc.2005.04.001. Semin Radiat Oncol. 2005. PMID: 16183479 Review.
-
The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.Mod Pathol. 2002 Oct;15(10):1087-95. doi: 10.1097/01.MP.0000028647.98725.8B. Mod Pathol. 2002. PMID: 12379756
Cited by
-
Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?J Carcinog. 2005 Jul 14;4:9. doi: 10.1186/1477-3163-4-9. J Carcinog. 2005. PMID: 16018800 Free PMC article.
-
[Pancreatic ductal adenocarcinoma and its precursors].Pathologe. 2005 Feb;26(1):12-7. doi: 10.1007/s00292-004-0735-0. Pathologe. 2005. PMID: 15630571 German.
-
High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.J Gastrointest Surg. 2008 Oct;12(10):1674-81; discussion 1681-2. doi: 10.1007/s11605-008-0628-2. Epub 2008 Aug 13. J Gastrointest Surg. 2008. PMID: 18704599
-
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.Diagn Pathol. 2021 Dec 13;16(1):117. doi: 10.1186/s13000-021-01178-0. Diagn Pathol. 2021. PMID: 34895278 Free PMC article.
-
BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.Mol Cancer. 2007 Dec 28;6:83. doi: 10.1186/1476-4598-6-83. Mol Cancer. 2007. PMID: 18163903 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous